New antibiotic shows promise in fighting tuberculosis

2 days ago1 min read

Preliminary findings from the phase 1B PanACEA trial shows promising results for a

new antibiotic, BTZ-043. The aim is to create an antibiotic that can treat MDR-TB. So

far, the trial has shown antibacterial efficacy in a cohort of 77 individuals with newly

diagnosed pulmonary TB. Read more here.

Recent Posts

A new study revealed that resistance is developing to the 6-month BPaLM regimen recommended by the WHO. The study investigated around...

A new initiative in Nigeria aims to provide state health insurance to any patient with drug resistant TB in the country. Implementation...

The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...